MedPath

Urotronic, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:3
Completed:2

Trial Phases

4 Phases

Early Phase 1:1
Phase 2:1
Phase 4:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (66.7%)
Early Phase 1
1 (11.1%)
Phase 2
1 (11.1%)
Phase 4
1 (11.1%)

EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures

Not Applicable
Not yet recruiting
Conditions
Ureteral Stricture
First Posted Date
2025-06-13
Last Posted Date
2025-06-13
Lead Sponsor
Urotronic Inc.
Target Recruit Count
60
Registration Number
NCT07020520

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Recruiting
Conditions
Benign Prostatic Hyperplasia
First Posted Date
2024-08-19
Last Posted Date
2025-03-10
Lead Sponsor
Urotronic Inc.
Target Recruit Count
500
Registration Number
NCT06560476
Locations
🇺🇸

Florida Urology Partners, Tampa, Florida, United States

🇺🇸

Sheldon Freedman, Ltd, Las Vegas, Nevada, United States

🇺🇸

Golden State Urology, Sacramento, California, United States

and more 5 locations

Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

Not Applicable
Recruiting
Conditions
Benign Prostatic Hyperplasia
First Posted Date
2024-03-15
Last Posted Date
2024-11-07
Lead Sponsor
Urotronic Inc.
Target Recruit Count
92
Registration Number
NCT06312722
Locations
🇺🇸

Arkansas Urology, Little Rock, Arkansas, United States

🇺🇸

Florida Urology Partners, LLP, Tampa, Florida, United States

🇺🇸

Ochsner LSU Health Shreveport - Regional Urology, Shreveport, Louisiana, United States

and more 2 locations

Optilume PoST AppRoval Clinical Evaluation of Andrology ParaMeters

Phase 4
Recruiting
Conditions
Urethral Stricture
First Posted Date
2022-05-20
Last Posted Date
2025-01-28
Lead Sponsor
Urotronic Inc.
Target Recruit Count
34
Registration Number
NCT05383274
Locations
🇺🇸

Arkansas Urology, Little Rock, Arkansas, United States

🇺🇸

Orlando Health, Orlando, Florida, United States

🇺🇸

Florida Urology, Tampa, Florida, United States

and more 6 locations

Optilume™ BPH Catheter System in Men With Symptomatic BPH

Not Applicable
Active, not recruiting
Conditions
Benign Prostatic Hyperplasia
First Posted Date
2019-10-18
Last Posted Date
2025-04-09
Lead Sponsor
Urotronic Inc.
Target Recruit Count
162
Registration Number
NCT04131907
Locations
🇺🇸

Arkansas Urology, Little Rock, Arkansas, United States

🇺🇸

Colorado Clinical Research, Golden, Colorado, United States

🇺🇸

Advanced Urology Institute, Daytona Beach, Florida, United States

and more 17 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.